Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions
Kidney Failure
Interventions
DRUG

epoetin beta (NeoRecormon ®)

"comparison of administration of high dosage of epoetin vs no administration of epoetin~30000 UI: 4 injections"

Trial Locations (17)

75

Necker Hospital, Paris

29200

LA CAVALE BLANCHE Hospital, Brest

31000

RANGUEIL Hospital, Toulouse

37044

BRETONNEAU Hospital, Tours

38000

MICHALLON Hospital, Grenoble

44093

CHU Nantes, Hotel-Dieu Hospital, Nantes

51100

MAISON BLANCHE Hospital, Reims

75015

Georges Pompidou European Hospital, Paris

75020

TENON Hospital, Paris

76230

Bois Guillaume Hospital, Rouen

80000

Amiens hospital, Amiens

86000

LA MILETRIE Hospital, Poitiers

92151

FOCH Hospital, Suresnes

94010

MONDOR Hospital, Créteil

94275

Kremlin Bicêtre Hospital, Le Kremlin-Bicêtre

59 000

ALBERT CALMETTE Hospital, Lille

06000

CHU Nice, Pasteur Hospital, Nice

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT00815867 - Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant | Biotech Hunter | Biotech Hunter